Citigroup
ISEE

Citigroup’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Citigroup’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-297,957
Closed -$11.7M – 5897
2023
Q2 		$11.7M Buy
297,957
+33,992
+13% +$1.2M 0.01% 1074
2023
Q1 		$6.42M Buy
263,965
+84,617
+47% +$1.85M ﹤0.01% 1356
2022
Q4 		$3.84M Sell
179,348
-172,698
-49% -$3.69M ﹤0.01% 1616
2022
Q3 		$6.32M Sell
352,046
-9,356
-3% -$123K ﹤0.01% 1413
2022
Q2 		$3.48M Buy
361,402
+297,620
+467% +$3.74M ﹤0.01% 1743
2022
Q1 		$1.07M Sell
63,782
-236,927
-79% -$3.5M ﹤0.01% 2897
2021
Q4 		$5.03M Buy
300,709
+175,692
+141% +$2.88M ﹤0.01% 1823
2021
Q3 		$2.03M Sell
125,017
-28,831
-19% -$314K ﹤0.01% 2539
2021
Q2 		$971K Sell
153,848
-45,375
-23% -$293K ﹤0.01% 3256
2021
Q1 		$1.23M Buy
199,223
+156,040
+361% +$947K ﹤0.01% 2831
2020
Q4 		$298K Buy
43,183
+39,121
+963% +$250K ﹤0.01% 4668
2020
Q3 		$23K Sell
4,062
-2,269
-36% -$10.8K ﹤0.01% 6109
2020
Q2 		$32K Buy
6,331
+41
+0.7% +$171 ﹤0.01% 6283
2020
Q1 		$22K Buy
6,290
+4,855
+338% +$28.4K ﹤0.01% 6640
2019
Q4 		$12K Sell
1,435
-259
-15% -$925 ﹤0.01% 7155
2019
Q3 		$2K Sell
1,694
-2,444
-59% -$2.84K ﹤0.01% 7568
2019
Q2 		$5K Sell
4,138
-4,820
-54% -$6.61K ﹤0.01% 7493
2019
Q1 		$12K Buy
8,958
+7,900
+747% +$11K ﹤0.01% 7190
2018
Q4 		$1K Sell
1,058
-150
-12% -$291 ﹤0.01% 7617
2018
Q3 		$2K Buy
1,208
+604
+100% +$1.5K ﹤0.01% 7627
2018
Q2 		$2K Buy
604
+27
+5% +$74 ﹤0.01% 7488
2018
Q1 		$2K Sell
577
-142
-20% -$412 ﹤0.01% 7395
2017
Q4 		$2K Sell
719
-1,900
-73% -$5.34K ﹤0.01% 7416
2017
Q3 		$7K Sell
2,619
-17,355
-87% -$46.9K ﹤0.01% 6788
2017
Q2 		$51K Buy
19,974
+11,478
+135% +$31.3K ﹤0.01% 5780
2017
Q1 		$31K Sell
8,496
-131,070
-94% -$554K ﹤0.01% 6023
2016
Q4 		$674K Buy
139,566
+95,584
+217% +$2.84M ﹤0.01% 4073
2016
Q3 		$2.03M Buy
43,982
+17,635
+67% +$994K ﹤0.01% 2494
2016
Q2 		$1.34M Sell
26,347
-9,048
-26% -$450K ﹤0.01% 2668
2016
Q1 		$1.5M Buy
35,395
+25,516
+258% +$1.3M ﹤0.01% 2855
2015
Q4 		$776K Sell
9,879
-10,241
-51% -$592K ﹤0.01% 3410
2015
Q3 		$816K Buy
20,120
+8,781
+77% +$465K ﹤0.01% 3296
2015
Q2 		$590K Buy
11,339
+3,522
+45% +$175K ﹤0.01% 3562
2015
Q1 		$363K Sell
7,817
-2,283
-23% -$119K ﹤0.01% 4032
2014
Q4 		$454K Buy
10,100
+9,443
+1,437% +$397K ﹤0.01% 3970
2014
Q3 		$26K Buy
657
+540
+462% +$21.2K ﹤0.01% 5740
2014
Q2 		$5K Sell
117
-1,336
-92% -$49K ﹤0.01% 6482
2014
Q1 		$52K Sell
1,453
-3,463
-70% -$117K ﹤0.01% 5467
2013
Q4 		$159K Buy
+4,916
New +$146K ﹤0.01% 4863

Citigroup's ISEE Position: Q3 2023 in Review

Citigroup sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 297,957 shares — an estimated $11.7M sold.

Citigroup first reported a position in ISEE in Q4 2013 and held it in 39 quarters. The position peaked at $11.7M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Citigroup reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Citigroup sold 297,957 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $11.7M.
  • Citigroup first reported a position in IVERIC bio, Inc. Common Stock in Q4 2013 and held it in 39 quarters.
  • Citigroup's IVERIC bio, Inc. Common Stock position peaked at $11.7M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Citigroup's 13F filing for Q3 2023, filed 9 Nov 2023.